4.20
price up icon0.96%   0.04
after-market 시간 외 거래: 4.23 0.03 +0.71%
loading
전일 마감가:
$4.16
열려 있는:
$4.32
하루 거래량:
112.69K
Relative Volume:
0.82
시가총액:
$1.47B
수익:
$842.96M
순이익/손실:
$-185.63M
주가수익비율:
-7.9863
EPS:
-0.5259
순현금흐름:
$-228.52M
1주 성능:
+10.24%
1개월 성능:
+5.79%
6개월 성능:
+0.96%
1년 성능:
-12.50%
1일 변동 폭
Value
$4.195
$4.3299
1주일 범위
Value
$3.96
$4.3299
52주 변동 폭
Value
$2.84
$5.6405

Evotec Se Adr Stock (EVO) Company Profile

Name
명칭
Evotec Se Adr
Name
전화
-
Name
주소
-
Name
직원
4,766
Name
트위터
Name
다음 수익 날짜
2025-04-17
Name
최신 SEC 제출 서류
Name
EVO's Discussions on Twitter

EVO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
EVO
Evotec Se Adr
4.20 1.47B 842.96M -185.63M -228.52M -0.5259
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
17.04 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
155.95 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.37 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.46 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.76 20.17B 16.54B -1.64B 749.00M -1.45

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-24 업그레이드 Deutsche Bank Sell → Hold
2024-10-07 다운그레이드 Jefferies Buy → Hold
2024-08-08 다운그레이드 Deutsche Bank Hold → Sell
2024-07-29 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2024-07-11 다운그레이드 Deutsche Bank Buy → Hold
2024-04-12 업그레이드 Deutsche Bank Hold → Buy
2024-01-18 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2023-06-23 업그레이드 Morgan Stanley Equal-Weight → Overweight
2023-06-16 다운그레이드 BofA Securities Buy → Neutral
2023-06-08 업그레이드 Citigroup Neutral → Buy
2023-04-04 업그레이드 Morgan Stanley Underweight → Equal-Weight
2022-12-09 개시 H.C. Wainwright Buy
2022-11-16 다운그레이드 Deutsche Bank Buy → Hold
2022-08-10 다운그레이드 Morgan Stanley Overweight → Underweight
2022-03-02 재개 Cowen Outperform
2022-01-07 재개 Citigroup Neutral
모두보기

Evotec Se Adr 주식(EVO)의 최신 뉴스

pulisher
Jun 04, 2025

8 New 4-Star Stocks - Morningstar

Jun 04, 2025
pulisher
May 24, 2025

Evotec SE ADR (EVO) Strikes $4.73: The Risk Seems Worthwhile At This Price - Stocksregister

May 24, 2025
pulisher
May 10, 2025

Evotec SE (EVO) Stock Forecasts - Yahoo Finance

May 10, 2025
pulisher
May 07, 2025

Evotec SE ADR earnings missed by $0.03, revenue fell short of estimates - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

Evotec Ag Earnings Call: Mixed Sentiment Amid Growth - TipRanks

May 07, 2025
pulisher
May 07, 2025

Evotec AG Reports Q1 2025 Earnings and Strategic Progress - TipRanks

May 07, 2025
pulisher
Apr 28, 2025

Stock Information - Evotec

Apr 28, 2025
pulisher
Apr 24, 2025

Evotec shares surge 51% following InvestingPro’s undervalued signal By Investing.com - Investing.com

Apr 24, 2025
pulisher
Apr 18, 2025

Evotec SE ADR earnings beat by $0.08, revenue topped estimates - Investing.com Australia

Apr 18, 2025
pulisher
Apr 17, 2025

Evotec SE Reports Strong Q4 2024 and New Strategy - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Evotec Ag’s Earnings Call: Growth Amid Challenges - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Evotec: Management Streamlines Strategy to Refocus on Core Strengths Amid Biologics Momentum - Morningstar

Apr 17, 2025
pulisher
Apr 11, 2025

Antibody Discovery Market Size to Achieve USD 22,570 Mn by 2034 | Statifacts - GlobeNewswire Inc.

Apr 11, 2025
pulisher
Dec 29, 2024

Evotec: Some Recovery Has Come, But Much More Is Expected - Seeking Alpha

Dec 29, 2024
pulisher
Dec 27, 2024

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid - MSN

Dec 27, 2024
pulisher
Nov 25, 2024

Markets Brief: Are Bank Stocks Expensive? - Morningstar

Nov 25, 2024
pulisher
Nov 22, 2024

Evotec SE withdraws acquisition offer - Investing.com

Nov 22, 2024
pulisher
Nov 18, 2024

Halozyme outlines plan to acquire Evotec for €2 billion By Investing.com - Investing.com UK

Nov 18, 2024
pulisher
Nov 17, 2024

Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says - BNN Bloomberg

Nov 17, 2024
pulisher
Nov 14, 2024

Halozyme proposes $2 billion acquisition of Evotec - Investing.com

Nov 14, 2024
pulisher
Nov 06, 2024

Evotec Reports Strategic Growth Amidst Revenue Challenges - TipRanks

Nov 06, 2024
pulisher
Aug 23, 2024

Annual General Meeting - Evotec

Aug 23, 2024
pulisher
Aug 23, 2024

Investor Relations - Evotec

Aug 23, 2024
pulisher
Aug 13, 2024

Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar

Aug 13, 2024
pulisher
Jun 06, 2024

Healthcare Sector - Morningstar

Jun 06, 2024
pulisher
May 23, 2024

Earnings call: Evotec SE Q1 2024 results show mixed performance amid challenges - Investing.com

May 23, 2024
pulisher
Apr 24, 2024

Evotec: Still A Speculative Buy After A Significant Decline (NASDAQ:EVO) - Seeking Alpha

Apr 24, 2024
pulisher
Nov 10, 2022

Evotec SE ADR earnings, Revenue miss in Q3 By Investing.com - Investing.com India

Nov 10, 2022
pulisher
Jun 15, 2022

Evotec (EVO) Inks Drug Discovery Collaboration Deal With J&J - Yahoo Finance

Jun 15, 2022
pulisher
Jan 21, 2012

Together for Medicines That MatterEvotec - Evotec

Jan 21, 2012
pulisher
May 11, 2010

Evotech and Roche subsidiary Genentech enter into drug discovery alliance - Proactive Investors USA

May 11, 2010
pulisher
Sep 09, 2009

Evotec and Biogen Idec in research agreement - Proactive financial news

Sep 09, 2009

Evotec Se Adr (EVO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$14.28
price down icon 0.07%
$8.93
price down icon 0.89%
$125.69
price up icon 0.22%
$287.35
price up icon 1.08%
drug_manufacturers_specialty_generic RDY
$15.03
price down icon 0.27%
$16.76
price up icon 0.00%
자본화:     |  볼륨(24시간):